United States Diagnostics & Research news

02:30 29 Jul 2026

nasdaq.com Earnings Main company 🇺🇸 United States

IQVIA (IQV) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

IQVIA Holdings (IQV) reported $4.37 billion in revenue for the quarter ended June 2026, representing a year-over-year increase of 8.7%. EPS of $3.15 for the same period compares to $2.81 a year ago. The reported revenue represents a surprise of +1.63% over the Zacks …

IQV main company

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%

02:11 29 Jul 2026

TradingView Earnings Main company 🇺🇸 United States

Biodesix, Inc. Revenue Breakdown – NASDAQ:BDSX

This document provides a revenue breakdown for Biodesix, Inc. (NASDAQ: BDSX), accessible through TradingView. It offers an overview of the company's financial information, including statements, statistics, dividends, earnings, and segment performance by source and country. The information is sourced from ICE Data Services, FactSet, …

BDSX main company

Sharemaestro market context Trend signal active 52 weeks +164.7% · Next-week setup negative 43.8%

01:37 29 Jul 2026

TradingKey Earnings Provider-linked mention 🇺🇸 United States

Amgen Inc Stock (AMGN) Moved Up by 4.02% on Jul 28: What Signal Does It Send?

Amgen Inc (AMGN) saw a 4.02% increase in its stock price, driven by strong second-quarter earnings that surpassed estimates and positive clinical data for its obesity drug MariTide. Technical indicators suggest a buy signal, though clinical safety concerns about MariTide and high pipeline dependency …

IQV mentioned

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%

01:10 29 Jul 2026

TradingKey Analyst action Provider-linked mention 🇺🇸 United States

IBIO|iBio Inc|Price:1.389|Chg%:-0.001

This article provides a comprehensive stock analysis of iBio Inc (IBIO) by TradingKey, highlighting its healthy fundamentals, high growth potential, and relatively fair valuation within the Biotechnology & Medical Research industry. Despite recent weak stock market performance, the company exhibits strong fundamentals, very high …

IQV mentioned

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%

01:10 29 Jul 2026

TradingKey Analyst action Provider-linked mention 🇺🇸 United States

IKT|Inhibikase Therapeutics Inc|Price:2.217|Chg%:-0.093

Inhibikase Therapeutics Inc (IKT) shows strong fundamentals and high growth potential, despite recent technical trends not fully supporting its performance. The company is considered fairly valued and has high institutional ownership. Analysts have given it a "Buy" rating with a target price indicating significant …

IQV mentioned

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%

00:42 29 Jul 2026

Moomoo Deals and strategy Main company 🇺🇸 United States

ICON Shares Rise on Anthropic Collaboration to Bring AI Across Clinical Trials

ICON plc (ICLR) saw its shares rise following an announcement of a collaboration with Anthropic, an AI safety and research company. This partnership aims to integrate Anthropic's generative AI, Claude, into ICON's clinical trial operations, enhancing efficiency, improving data analysis, and accelerating patient outcomes. …

ICLR main company

Sharemaestro market context Trend signal active 52 weeks -7.2%

00:36 29 Jul 2026

scanx.trade Earnings Main company 🇺🇸 United States

Agilent Technologies Q3 Results: Earnings call set for Aug 26

Agilent Technologies Inc. will report its third-quarter fiscal year 2026 financial results after market close on August 26th. A conference call will follow at 1:30 p.m. PDT to discuss the company's performance and operational trends. In fiscal year 2025, Agilent Technologies generated $6.95 billion …

A main company

Sharemaestro market context Trend signal active 52 weeks +22.8% · Next-week setup negative 44.0%

00:33 29 Jul 2026

GuruFocus Earnings Main company 🇺🇸 United States

Revvity Inc (RVTY) Stock Up 3.2% and Still Undervalued -- GF Sco

Revvity Inc (RVTY) shares rose 3.2% to $111.51, reflecting a 15.5% year-to-date gain, yet the stock is considered 7.5% undervalued with a GF Value of $120.57. Despite an attractive valuation rank of 10/10, its growth rank is low at 3/10, and the P/E ratio …

RVTY main company

Sharemaestro market context Trend signal active 52 weeks +24.4%

00:10 29 Jul 2026

TradingKey Earnings Provider-linked mention 🇺🇸 United States

GLMD|Galmed Pharmaceuticals Ltd|Price:0.543|Chg%:+0.009

This article provides a comprehensive stock analysis of Galmed Pharmaceuticals Ltd (GLMD), highlighting its stable fundamentals, high growth potential, and fair valuation compared to its industry peers. The company's main focus is on developing Aramchol for treating non-alcoholic steatohepatitis (NASH). Despite average recent stock …

IQV mentioned

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%

00:10 29 Jul 2026

TradingKey Earnings Provider-linked mention 🇺🇸 United States

GERN|Geron Corp|Price:1.415|Chg%:-0.035

This article provides a comprehensive stock analysis of Geron Corp (GERN) by TradingKey, highlighting its stable fundamentals, high growth potential, and fair valuation within the Biotechnology & Medical Research industry. Despite positive analyst ratings and recent market outperformance, technical indicators suggest the stock is …

IQV mentioned

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%

23:42 28 Jul 2026

TradingView Earnings Main company 🇺🇸 United States

Illumina, Inc. Revenue Breakdown – LSX:927079

This article provides a revenue breakdown for Illumina, Inc. (LSX:927079), detailing its performance in the last fiscal year. The company generated 3.70 billion EUR, with its Core Illumina - Consumables segment being the top contributor at 2.75 billion EUR. Geographically, the United States was …

ILMN main company

Sharemaestro market context Trend signal active 52 weeks +87.5%

23:40 28 Jul 2026

TradingView Earnings Main company 🇺🇸 United States

Fulgent Genetics Inc expected to post a loss of 46 cents a share - Earnings Preview

Fulgent Genetics Inc (FLGT) is projected to report a loss of 46 cents per share in its upcoming earnings announcement. This preview indicates the anticipated financial performance for the company, suggesting a negative earnings per share.

FLGT main company

Sharemaestro market context Price above Trend Line 52 weeks -14.7% · Next-week setup negative 42.1%

23:40 28 Jul 2026

Pluang Earnings Main company 🇺🇸 United States

Veracyte to present at two major healthcare investor conferences in August and September 2026

Veracyte, a cancer diagnostics company, announced its participation in two key healthcare investor conferences: the Canaccord Genuity Growth Conference in August and the Morgan Stanley Global Healthcare Conference in September 2026. The company will conduct fireside chats at both events to discuss its diagnostic …

VCYT main company

Sharemaestro market context Trend signal active 52 weeks +33.1%

23:38 28 Jul 2026

TradingView Analyst action Main company 🇺🇸 United States

IQVIA Holdings, Inc. Stock 12‑Month Price Target Raised to $232.22, Implies 9% Upside

Analysts have raised the average 12-month price target for IQVIA Holdings, Inc. (IQV) stock to $232.22, up from $230. This new target suggests a potential upside of approximately 9% based on the recent closing price. The consensus rating for IQV remains a "Buy" among …

IQV main company

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%

23:10 28 Jul 2026

TradingKey Analyst action Provider-linked mention 🇺🇸 United States

FMS|Fresenius Medical Care AG|Price:24.880|Chg%:+0.130

This article provides a comprehensive stock analysis of Fresenius Medical Care AG (FMS), highlighting its relatively healthy fundamentals, high growth potential, and fair valuation. It notes high institutional ownership and a medium-term upward trend prediction for the stock price, despite technicals not fully supporting …

DGX mentioned LH mentioned

Sharemaestro market context Trend signal active 52 weeks +31.8% · Next-week setup positive 58.1%

23:06 28 Jul 2026

nasdaq.com Earnings Main company 🇺🇸 United States

Why Opko Health Stock Surged by 33% on Tuesday

Key Points Investors were also cheered by a substantial narrowing of the company's net loss. Ditto for the raised full-year revenue guidance.10 stocks we like better than Opko Health › Opko Health(NASDAQ: OPK) was one of the healthier stocks on the exchange Tuesday. Its …

OPK main company

Sharemaestro market context Trend signal active 52 weeks -2.1%

22:41 28 Jul 2026

Stock Titan Deals and strategy Main company 🇺🇸 United States

BlackRock (GRAL holder) discloses 7.9% GRAIL, Inc. stake in 13G/A

BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 7.9% passive ownership stake in GRAIL, Inc. (GRAL). This ownership amounts to 3,376,085 shares of GRAIL common stock, with BlackRock holding sole voting power over 3,312,474 shares and sole dispositive power over all 3,376,085 …

GRAL main company

Sharemaestro market context Price above Trend Line 52 weeks +98.2% · Next-week setup positive 61.9%

22:41 28 Jul 2026

MarketBeat Earnings Main company 🇺🇸 United States

NeoGenomics (NASDAQ:NEO) Posts Earnings Results, Beats Expectations By $0.02 EPS

NeoGenomics (NASDAQ:NEO) reported quarterly earnings that surpassed analyst expectations, with an EPS of $0.05 against an estimated $0.03, and revenue of $201.66 million, exceeding the $196.93 million estimate. Despite the positive earnings surprise, the company posted a negative net margin and return on equity. …

NEO main company

Sharemaestro market context Trend signal active 52 weeks +141.3% · Next-week setup negative 40.8%

22:41 28 Jul 2026

Investing.com Earnings Main company 🇺🇸 United States

Earnings call transcript: NeoGenomics tops Q2 2026 estimates and lifts outlook

NeoGenomics Inc. reported strong second-quarter 2026 earnings, surpassing Wall Street expectations for both profit and sales, driven by robust clinical and next-generation sequencing (NGS) business growth. The company raised its full-year 2026 revenue and adjusted EBITDA guidance, despite continued weakness in its non-clinical pharma …

NEO main company

Sharemaestro market context Trend signal active 52 weeks +141.3% · Next-week setup negative 40.8%

22:12 28 Jul 2026

Kalkine Media Earnings Main company 🇺🇸 United States

Fulgent Genetics CSO Gao Hanlin Executes Tax-Related Sale of 1,645 Shares at $19.67 on July 26, 2026

Gao Hanlin, Chief Scientific Officer of Fulgent Genetics, Inc. (NASDAQ: FLGT), sold 1,645 common shares at $19.67 each on July 26, 2026, to cover tax obligations. Following this transaction, Hanlin still directly owns 988,729 common shares in the genomics testing company. The sale was …

FLGT main company

Sharemaestro market context Price above Trend Line 52 weeks -14.7% · Next-week setup negative 42.1%

21:41 28 Jul 2026

Stock Titan Earnings Main company 🇺🇸 United States

BlackRock (NYSE: BLK) discloses 5.5% beneficial ownership in GeneDx (WGS)

BlackRock, Inc. has filed a Schedule 13G disclosing a 5.5% beneficial ownership in GeneDx Holdings Corp. (WGS). The filing indicates BlackRock owns 1,622,518 shares of Class A stock, with sole voting power over 1,588,670 shares and sole dispositive power over all 1,622,518 shares. No …

WGS main company

Sharemaestro market context Price above Trend Line 52 weeks -39.3%

21:41 28 Jul 2026

AlphaStreet Earnings Main company 🇺🇸 United States

NeoGenomics Releases Q2 2026 Financial Results

NeoGenomics, Inc. reported strong Q2 2026 financial results, with adjusted EPS of $0.05, significantly beating analyst estimates, and revenue of $201.7M, surpassing consensus. The company saw an 11.2% increase in revenue year-over-year, primarily driven by its clinical services segment. Management provided full-year adjusted EPS …

NEO main company

Sharemaestro market context Trend signal active 52 weeks +141.3% · Next-week setup negative 40.8%

21:41 28 Jul 2026

TradingView Earnings Main company 🇺🇸 United States

IQVIA HOLDINGS INC. 2Q 2026: Revenue $4.37B, EPS $1.53— 10-Q Summary

IQVIA Holdings Inc. (IQV) reported its second-quarter 2026 results, showing an 8.7% year-over-year revenue increase to $4.37 billion. However, diluted EPS slightly declined to $1.53, and net income fell to $258 million. The company has reorganized into Commercial Solutions and R&D Solutions segments and …

IQV main company

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%

21:40 28 Jul 2026

Stock Titan Market update Main company 🇺🇸 United States

Natera (NTRA) insider Michael Brophy files to sell 1,178 shares, lists prior sales

Natera executive Michael Brophy has filed a notice to sell 1,178 shares of common stock, stemming from Restricted Stock Units dated July 26, 2026. This SEC Form 144 filing also details several previous sales of Natera stock by Brophy over the past three months, …

NTRA main company

Sharemaestro market context Trend signal active 52 weeks +87.2% · Next-week setup positive 57.5%

21:40 28 Jul 2026

Stock Titan Market update Main company 🇺🇸 United States

Jonathan Sheena of NTRA plans 188-share stock sale (NASDAQ: NTRA)

Jonathan Sheena, an insider at Natera, Inc. (NASDAQ: NTRA), has filed a notice to sell 188 shares of common stock on July 28, 2026, with an estimated aggregate value of $48,509.64. This planned sale is related to 6,208 Restricted Stock Units granted in January …

NTRA main company

Sharemaestro market context Trend signal active 52 weeks +87.2% · Next-week setup positive 57.5%

21:40 28 Jul 2026

TradingKey Earnings Provider-linked mention 🇺🇸 United States

CRVO|CervoMed Inc|Price:2.555|Chg%:-0.005

This article provides a comprehensive stock analysis of CervoMed Inc (CRVO) by TradingKey. It highlights that CervoMed's fundamentals are healthy with significant growth potential, although its valuation is considered fairly valued within the Biotechnology & Medical Research industry. Analysts overwhelmingly rate it as a …

IQV mentioned

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%

21:24 28 Jul 2026

Stock Titan Earnings Main company 🇺🇸 United States

Thermo Fisher (NYSE: TMO) COO sells 400 shares under 10b5-1 plan

Thermo Fisher Scientific Inc.'s President & COO, Gianluca Pettiti, sold 400 shares of common stock for $565.00 per share on July 27, 2026. This transaction, totaling $226,000, was conducted under a Rule 10b5-1 trading plan adopted in September 2025. Following the sale, Pettiti directly …

TMO main company

Sharemaestro market context Trend signal started 52 weeks +18.1%

21:15 28 Jul 2026

TradingKey Earnings Main company 🇺🇸 United States

Thermo Fisher Scientific Inc Stock (TMO) Closed Up by 3.20% on Jul 28: Drivers Behind the Movement

Thermo Fisher Scientific (TMO) stock increased by 3.20% due to strong quarterly earnings that surpassed estimates and an increased full-year organic revenue growth forecast. The company benefits from rising biopharma spending, demand for clinical services, and increased capital expenditure from pharmaceutical clients. Technical indicators …

TMO main company

Sharemaestro market context Trend signal started 52 weeks +18.1%

21:11 28 Jul 2026

Barron's Market update Main company 🇺🇸 United States

U.S. Markets Finished Mixed Tuesday As IQVIA Holdings Led, Amkor Technology Lagged

U.S. stock indexes ended Tuesday mixed, with the Dow Jones Industrial Average rising by 1.03% and the S&P 500 Index increasing by 0.21%. Conversely, the NASDAQ Composite Index experienced a slight decline of 0.22%. IQVIA Holdings led the market, while Amkor Technology lagged.

IQV main company

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%

21:10 28 Jul 2026

Stock Titan Market update Main company 🇺🇸 United States

OPKO Health (OPK) VP withholds 53,266 shares for taxes

OPKO Health's Executive VP-Administration, Steven D. Rubin, reported a tax-related share withholding on July 24, 2026. A total of 53,266 shares of common stock, valued at $1.22 per share, were withheld to cover tax obligations stemming from vested restricted stock units. Following this transaction, …

OPK main company

Sharemaestro market context Trend signal active 52 weeks -2.1%

21:05 28 Jul 2026

globenewswire.com Market update Main company 🇺🇸 United States

Veracyte to Participate in Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., July 28, 2026 (GLOBE NEWSWIRE) -- Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, announced today that it will be participating in the following investor conferences: Canaccord Genuity 46th Annual Growth Conference – Boston, MA Fireside chat on Tuesday, …

VCYT main company

Sharemaestro market context Trend signal active 52 weeks +33.1%

21:03 28 Jul 2026

Stock Titan Market update Main company 🇺🇸 United States

METTLER TOLEDO INTERNATIONAL INC/ SEC Filing (Jul 28, 2026)

This article reports on a Form 144 SEC filing by METTLER TOLEDO INTERNATIONAL INC. (MTD) on July 28, 2026. The filing indicates a proposed sale of 832 shares of common stock acquired through a stock option exercise on November 3, 2016, with an aggregate …

MTD main company

Sharemaestro market context Price above Trend Line 52 weeks +7.4% · Next-week setup positive 57.4%

20:41 28 Jul 2026

GlobeNewswire Regulatory and legal Main company 🇺🇸 United States

GRAL 1-WEEK DEADLINE ALERT: GRAIL, Inc. (NASDAQ: GRAL)

Hagens Berman Sobol Shapiro LLP has filed a securities fraud class action lawsuit against GRAIL, Inc. (NASDAQ: GRAL), urging investors with substantial losses to join before the August 4, 2026, lead plaintiff deadline. The lawsuit alleges that GRAIL and its executives misled investors about …

GRAL main company

Sharemaestro market context Price above Trend Line 52 weeks +98.2% · Next-week setup positive 61.9%

20:41 28 Jul 2026

GlobeNewswire Regulatory and legal Main company 🇺🇸 United States

WGS 6-DAY DEADLINE ALERT: GeneDx Holdings Corp. (NASDAQ: WGS) Investors Urged to Contact Hagens Berman; Securities Fraud Class Action Filed, August 3, 2026 Lead Plaintiff Deadline

Hagens Berman Sobol Shapiro LLP has filed a securities fraud class action lawsuit against GeneDx Holdings Corp. (NASDAQ: WGS), urging investors with substantial losses to contact the firm before the August 3, 2026, lead plaintiff deadline. The lawsuit alleges GeneDx misled investors about the …

WGS main company

Sharemaestro market context Price above Trend Line 52 weeks -39.3%

20:40 28 Jul 2026

Stock Titan Market update Main company 🇺🇸 United States

Michael Brophy plans Natera (NTRA) stock sale after recent trades

Insider Michael Brophy has filed a Form 144 notice indicating his intent to sell 1,222 shares of Natera (NTRA) common stock. These shares originate from Restricted Stock Units granted on January 27, 2023. The filing also details Brophy's previous sales of Natera stock over …

NTRA main company

Sharemaestro market context Trend signal active 52 weeks +87.2% · Next-week setup positive 57.5%

20:40 28 Jul 2026

Stock Titan Market update Main company 🇺🇸 United States

Natera insider plans sale of 988 shares | NTRA SEC Filing - Form 144

Daniel Rabinowitz, an insider at Natera (NTRA), has filed a Form 144 to sell 988 shares of common stock, valued at $254,933.64, on or after July 28, 2026. The filing also details previous sales by Rabinowitz, including 33,600 shares for over $8.4 million on …

NTRA main company

Sharemaestro market context Trend signal active 52 weeks +87.2% · Next-week setup positive 57.5%